Professional Experience
Dr. Fristrup has developed a comprehensive clinical career marked by leadership in patient care and participation in cutting-edge research projects. He has successfully led multiple clinical trials and has mentored young physicians and researchers, helping to shape the next generation of oncology specialists. His hands-on experience with complex cancer cases has made him a sought-after consultant for both patients and colleagues.
- Consultant in Oncology: Aarhus University Hospital, leading treatment of metastatic kidney cancer
- Principal Investigator: NORDIC SUN trial and other clinical research initiatives
- Mentorship and Leadership: Guiding medical students, junior clinicians, and research fellows in oncology practice
Academic Contributions
Dr. Fristrup is highly active in academia, where he contributes to the education of medical students, the development of training programs, and ongoing research in oncology. He frequently presents his findings at conferences and workshops, sharing insights that help advance clinical practices in kidney cancer treatment. His teaching emphasizes practical application of research in everyday patient care.
- Associate Professor: Department of Clinical Medicine, Aarhus University
- Lecturer: Courses for medical students and postgraduate trainees, focusing on oncology and clinical research
- Research Interests: Molecular markers, prognostic tools, targeted therapy, and clinical trials in kidney cancer
- Conference Speaker: National and international oncology forums, contributing to global knowledge sharing
Areas of Expertise
Dr. Fristrup’s clinical practice focuses on precision oncology, with an emphasis on personalized treatment plans for patients with metastatic kidney cancer. His expertise includes the latest therapies, including immunotherapy and targeted treatments, ensuring patients receive care based on the most recent scientific evidence. He is also experienced in managing complex cases that require multidisciplinary collaboration.
- Metastatic Kidney Cancer: Personalized treatment for advanced stages, improving patient outcomes
- Immunotherapy: Harnessing the immune system to fight cancer effectively
- Targeted Therapy: Precision medicine approaches for optimal treatment efficacy
- Clinical Trials: Leading innovative studies to test new treatment strategies and improve patient care
Publications and Research
Dr. Fristrup has made significant contributions to scientific literature, publishing research that informs both clinical practice and future investigations. His work focuses on understanding molecular markers and optimizing treatments to enhance patient survival and quality of life. He is recognized for translating complex scientific findings into practical approaches for treating kidney cancer.
- Soluble CD206 in metastatic renal cell carcinoma: Relation to clinical–biochemical parameters and patient outcome: Investigates molecular markers associated with patient prognosis and potential therapeutic targets.
- Therapeutic drug monitoring (TDM) of tyrosine kinase inhibitors (TKI) for optimized outcome in patients with metastatic renal cell carcinoma: Focuses on improving the safety and effectiveness of targeted therapies.
- Titrating Cabozantinib in Metastatic Renal Cell Carcinoma Patients Using Goldilocks Principle: A Real-World Evidence Study: Evaluates real-world treatment adjustments to maximize patient benefits while minimizing side effects.
Patient Care Philosophy
Dr. Fristrup believes that effective cancer treatment requires both scientific precision and compassionate care. He prioritizes understanding each patient’s unique circumstances and communicates treatment options clearly, enabling informed decisions. His approach is inclusive, culturally sensitive, and supportive, ensuring that patients feel respected and empowered throughout their care journey.
- Patient-Centered Approach: Tailors treatment plans to individual needs and preferences
- Clear Communication: Explains complex medical concepts in a simple, understandable way
- International Patient Care: Offers guidance and pre-consultation support for patients from abroad
- Focus on Patient Satisfaction: Emphasizes empathy, cultural sensitivity, and positive treatment outcomes
Professional Affiliations
Dr. Fristrup maintains active membership in leading professional organizations, supporting continuous learning, collaboration, and contribution to oncology research and practice. His affiliations help him stay updated on the latest advancements and maintain high standards of clinical excellence.
- Danish Society for Clinical Oncology: Active member
- European Society for Medical Oncology (ESMO): Member
- Board Certifications: Licensed medical doctor in Denmark
FAQs
- Is Dr. Niels Fristrup board-certified?
- Yes, Dr. Fristrup is a licensed medical doctor in Denmark specializing in oncology.
- What types of surgeries does he perform?
- He focuses on surgical and targeted treatments for metastatic kidney cancer.
- Does he treat international patients?
- Yes, Dr. Fristrup offers support and pre-consultation options for international patients.
- How long is the typical hospital stay?
- Hospital stays vary depending on the treatment plan and patient-specific factors.
- What languages does he speak?
- Dr. Fristrup is fluent in Danish and English.
- What are his research interests?
- He focuses on molecular markers, prognostic tools, and optimizing therapies for kidney cancer.
- Does he participate in clinical trials?
- Yes, he is the principal investigator of several trials including the NORDIC SUN trial.
